Patient Registry Software Market Growth
The global patient registry software market was valued at $993.3 million in 2021, and is projected to reach $2,508.27 million by 2031, growing at a CAGR of 9.7% from 2022 to 2031. The report offers a detailed analysis of changing market trends, top segments, key investment pockets, value chain, regional landscape, and competitive scenario. The report is a helpful source of information for leading market players, new entrants, investors, and stakeholders in devising strategies for the future and taking steps to strengthen their position in the market.
There are different purposes for using of patient registries software. According to the National Institutes of Health, Registries can be used to recruit patients for clinical trials to learn about a particular disease or condition, to develop therapeutics, or to learn about population behavior patterns and their association with disease development. Patient registries can also be used to monitor outcomes and study best practices during the course of the treatment. They may pursue a specific, focused research agenda, may collect data for a limited time to answer a specific research question, or may collect data on an indefinite basis to answer a variety of existing and emerging research questions. Patient registries may also include the collection of tissue or blood samples collected in a variety of ways. The creation and use of researcher-generated patient registries has grown steadily for several decades. The examples of individual researcher-generated registries can be found at the AHRQ Registry of Patient Registries.
Download Free Sample Report: https://www.alliedmarketresearch.com/request-sample/2825
Major driving factors of patient registry software market size include increase in the usage of electronic health records (EHRs), rise in prevalence of chronic diseases, surge in government support for healthcare, rise in geriatric population and increase in potential benefits of patient registry in hospitals and research organizations. Furthermore, increase in usage of the stored data for post-marketing surveillance and surge in government initiatives to build patient registries boost the growth of the market. However, concerns related to the security and privacy of the data and dearth of skilled resources hinder the market growth. Conversely, the increase in awareness regarding technologies is expected to create lucrative opportunities for the patient registry software market growth.
Patient Registry Software Market Segmentation
Based on registry type, the disease registry segment held the largest share in 2021, contributing to nearly three-fifths of the global patient registry software market, and is likely to maintain its leadership status during the forecast period. Moreover, the same segment is expected to manifest the highest CAGR of 10.3% from 2022 to 2031.
Based on software type, the integrated segment held the largest share in 2021, accounting for nearly three-fifths of the global patient registry software market, and would rule the roost through 2031. Moreover, the same segment is estimated to witness the fastest CAGR of 10.3% during the forecast period.
Based on end user, the government and third party organizations segment was the largest in 2021, accounting for around one-third of the global patient registry software market, and is likely to maintain its leadership status during the forecast period. However, the pharma, biotech and medical device companies segment is expected to manifest the highest CAGR of 11.2% from 2022 to 2031.
Based on region, the market in North America accounted for more than half of the global patient registry software market in 2021, and is likely to maintain its leadership status during the forecast period. However, the Asia-Pacific market is expected to manifest the highest CAGR of 11.3% from 2022 to 2031.
Leading players of the global patient registry software market analyzed in the research include Conduent, Inc., Dacima Software Inc., Elekta AB (pub), FIGmd, Inc., IBM Corp, ImageTrend Inc., IQVIA Holdings, McKesson Corporation, OpenText Corporation, Optum, Inc., Ordinal Data, Inc., and Premier, Inc.
The report analyzes these key players of the global patient registry software market. These players have adopted various strategies such as expansion, new product launches, partnerships, and others to increase their market penetration and strengthen their position in the industry. The report is helpful in determining the business performance, operating segments, product portfolio, and developments by every market player.
Read More:
Global Veterinary Imaging Market Set for Strong Growth Through 2030
Ophthalmology Devices Market to reach $11.6 billion by 2033 | Asia Pacific: Fastest growing market
Contact Details:
David Correa
USA/Canada (Toll Free): +1-800-792-5285, +1-503-894-6022
About Us
Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of “Market Research Reports” and “Business Intelligence Solutions.” AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.
